GXO Logistics (GXO) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
11 Apr, 2026Executive summary
Achieved record Q4 and full-year 2025 revenue and adjusted EBITDA, with organic growth in every region and over $1.1 billion in new business wins for 2025; incremental 2026 new business revenue up over 20% year-over-year.
Announced new leadership in commercial, operations, North America, Americas, and Asia Pacific to drive global alignment, operational consistency, and margin expansion.
Wincanton integration progressing as planned, targeting $60 million in synergies by end of 2026.
Strategic focus on accelerating organic growth in B2B verticals: life sciences, aerospace & defense, industrial, technology, and deploying AI and robotics for productivity and differentiation.
Financial highlights
Q4 2025 revenue reached $3.5 billion, up 7.9% year-over-year, with 3.5% organic growth; Q4 adjusted EBITDA was $255 million; Q4 net income was $43 million; adjusted net income $101 million.
Full-year 2025 revenue was $13.2 billion, up 12.5% (3.9% organic); adjusted EBITDA was $881 million; adjusted diluted EPS was $2.51.
Free cash flow for 2025 was $259 million; Q4 free cash flow was $163 million.
Adjusted EBITDA margin for 2025 was 6.7%; Q4 2025 adjusted EBITDA margin was 7.3%.
Adjusted diluted EPS for Q4 2025 was $0.87.
Outlook and guidance
2026 guidance: organic revenue growth of 4%-5%, adjusted EBITDA of $930-$970 million (up 8% at midpoint), adjusted diluted EPS of $2.85-$3.15 (up 20% at midpoint), and adjusted EBITDA to free cash flow conversion of 30%-40%.
Guidance assumes flat customer volumes, with growth driven by new business wins and pipeline conversion.
Margin expansion of ~20 basis points expected in 2026, with further upside possible from productivity initiatives and higher pipeline conversion.
Latest events from GXO Logistics
- Record revenue, board refreshment, and strong ESG focus highlight this year's proxy.GXO
Proxy filing22 Apr 2026 - Q2 revenue up 19% to $2.85B, but net income down 41% amid acquisition and litigation costs.GXO
Q2 20242 Feb 2026 - Q3 revenue up 28% to $3.2B, strong pipeline, but net income down on higher costs.GXO
Q3 202416 Jan 2026 - Record 2024 results and strong 2025 outlook with margin expansion and robust pipeline.GXO
Q4 202415 Dec 2025 - 2024 saw record results, board refreshment, and a focus on ESG and pay-for-performance.GXO
Proxy Filing1 Dec 2025 - Q2 2025 revenue up 16%, guidance raised, Wincanton deal approved, CEO transition underway.GXO
Q2 202523 Nov 2025 - Q1 revenue up 21% to $3B, net loss $95M, guidance reaffirmed, and NHS contract boosts outlook.GXO
Q1 202519 Nov 2025 - Record Q3 revenue, 71% net income growth, and robust pipeline drive strong outlook.GXO
Q3 202513 Nov 2025